$85.96
-1.49-1.70%
At close: Jun 5, 5:00 PM EST
$85.95
-0.01-0.01%
After Hours: Jun 5, 5:58 PM EST
Edwards Lifesciences Corp Stock Guidance
EWNYSE
Edwards Lifesciences (EW) last issued guidance on April 23, 2026 for fiscal year 2026. The company guided earnings per share in the range of $2.95 - $3.05, compared to a consensus EPS estimate of $2.97. Edwards Lifesciences also guided revenue in the range of $6.50B - $6.90B for the period.
Compared to prior guidance, Edwards Lifesciences maintained its EPS outlook from a previous range of $2.90 - $3.05. On the revenue side, the company raised its revenue forecast from a prior range of $6.55B - $6.67B.
Edwards Lifesciences has issued 40 guidance updates between July 28, 2022 and April 23, 2026. During this period, the company raised its outlook 6 times and lowered it 18 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Apr 23, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$2.95 - $3.05
Revenue Guidance Range
$6.50B - $6.90B
Edwards Lifesciences Guidance History
Review all historical guidance issued by Edwards Lifesciences, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Edwards Lifesciences (EW)?
The most recent guidance for Edwards Lifesciences (EW) was reported on April 23, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $2.95 to $3.05, compared to the estimated EPS of $2.97. Additionally, Edwards Lifesciences forecasted revenue between $6.50B and $6.90B for the period.
What EPS range did Edwards Lifesciences (EW) guide for?
Edwards Lifesciences (EW) guided EPS in the range of $2.95 to $3.05 for the fiscal year 2026. The consensus analyst EPS estimate is $2.97.
What revenue range did Edwards Lifesciences (EW) guide for?
Edwards Lifesciences (EW) guided revenue in the range of $6.50B to $6.90B for the fiscal year 2026.
Did Edwards Lifesciences (EW) raise or lower guidance?
Edwards Lifesciences (EW) maintained its EPS guidance from a prior range of $2.90 - $3.05 to $2.95 - $3.05 for the fiscal year 2026.
When did Edwards Lifesciences (EW) last issue guidance?
Edwards Lifesciences (EW) last issued guidance on April 23, 2026 for the fiscal year 2026.
